Swiss stocks - Factors to watch on Sept 25 - Reuters

Swiss stocks - Factors to watch on Sept 25
Reuters
Immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said. For more news see. SWATCH. The watch group posted “very positive” sales growth in September, continuing an upward ...

and more »

(Source: Market News via Google News)